Bullish option flow detected in Bristol Myers (BMY) Squibb with 11,821 calls trading, 2x expected, and implied vol increasing almost 2 points to 27.82%. May-25 67.5 calls and Mar-25 60 calls are the most active options, with total volume in those strikes near 10,200 contracts. The Put/Call Ratio is 0.03. Earnings are expected on April 24th.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BMY:
- Bristol Myers’ treatment of small cell lung cancer gets FDA orphan designation
- Actinium Pharmaceuticals launches clinical trial for Actimab-A in combination
- Big pharma fears drug price spikes in US-EU tariff spat, Reuters says
- Perspective Therapeutics says first patient dosed in Phase 1/2a trial of VMT01
- Bristol Myers announces EC approval of Breyanzi